641
|5584220010018
12356422200100286499
/36168040010732
Vnitř3693804001074592111139166
Lék.3878804001074184122140
2025;71(2):119-1234038804001074487128172185226267286328351365402437475504543580624
/47078040010732
VNITŘNÍ48048040010746107127172221280301
LÉKAŘSTVÍ5127804001074084130188235279325377399
www.casopisvnitrnilekarstvi.cz42580400107651332012142542953293774274464795215705896176436927117307748128548809159449871007102310631101
FARMAKOLOGICKÝ465522001003983129195242289338373423469489529576625
PROFIL529522001004388139179198233
Kyselina430233001004376106142157172210245
bempedoová456333001003773133171207246284324359395
–4974330010038
praktický50283300100376197131160176206241279
pohled532333001003777115130165204
nem42562001074890161
už60062001074782
do69662001074895
kombinace80562001073783155202220266305343384
kyselina120362001073778111153171188233272
bempedoová148962001074992164211254302349396434474
nezávisle197762001074790125165203221252269312
na230262001074887
užití240362001074782100126143
ezetimibu256062001074379120146163234251299345
hrazena42576001074874114151193240280
z719760010737
prostředků77176001074975121154182208250299336383
veřejného116976001074083108150167214258305353
zdravotního153676001073784110150189235262309327376423
pojištění197476001075098116134166193235282299
není.228876001074992139157171
Tito24747600107426289135
pacienti262476001075090130148190238264281
si42590001073451
pak49790001074990127
mohou645900010773121169216264
kyselinu92990001073880113157175192239286
bempedoovou123690001074993166215259308355403443489537
sami179390001073475147165
hradit,197990001074873114162180207223
pokud222290001075098136183232
je247490001072063
třeba,25579000107285496144185200
aby277890001074089128
kombinační425104001073884158206225272311351398416
léčbou862104001071963103151199247
dosáhli1130104001074997129170218236253
cílové140510400107405877125164206
hladiny1633104001074866106155172219257
LDL-cholesterolu1912104001074097137155196243291310353385414455481527546592
(konkrétně2526104001072461108155192220262289336379
v4251180010741
naší487118001074988121138
lipidové64711800107193785103152199238281
poradně949118001075098124165214261304
máme12751180010773113186229
takové1526118001072868105152191234
dva1781118001074990130
muže19331180010774120156198
po2153118001075098
srdečním2273118001073358106149189236254326
infarktu,262111800107196688130155193223270284
kteří425132001073868110135153
jsou59313200107195199146
absolutními754132001074190122170188235262310327400418
intoleranty118713200107186591137156199225265312338380
statinů1582132001073462102128146193240
i18371320010719
ezetimibu1871132001074380122148166239257305353
a22391320010740
přidáním229413200107507694142182229247320
kyseliny2629132001073880113156174192239276
bempedoové425146001075095168217262312359408448491
jako94114600107195997143
samoplátci1109146001073476149197247266306333371389
k15231460010738
užívání1586146001074884103144185232250
PCSK9i1861146001074697139183227245
dosáhli2131146001074997130172220238256
cílové241214600107405878126166209
hladiny2646146001074867107156174221259
LDL-cholesterolu425160001074097137154196242290308351384412453479525543589
pro1029160001075076121
velmi1165160001074183101173191
vysoké1370160001074183116163201243
KV1627160001074594
riziko).17351600010727458199135182202214
Tabulka1964160001074276124171189226267
222461600010743
shrnuje2304160001073480105153200217260
potenciál2579160001074997124165212252269308326
kombinační425174001073884158206225272311351398416
léčby859174001071962102150189
kyseliny1066174001073880113156174192239276
bempedoové1360174001075094167215259309356404444486
s18641740010733
dalšími1915174001074989107139156229246
hypolipidemiky.2179174001074886136184203220269287335378451469506548559
Závěr3047590013862123184242288
Snižování318776001074189107143189229270318336
LDL-cholesterolu353976001074098138156198246294313357390419461487533553600
s4155760010733
cílem42057600107395878122195
snížení44167600107338199135177225243
KV467576001074594
rizika47857600107274682101138180
a4981760010741
s5038760010734
ním508876001074866139
spojené524376001073482131150193241284
snížení30479000107338199135177225243
morbidity3306900010774122148198217265284311354
a3676900010740
mortality3733900010773121147178219238256283325
je407590001071962
paradigmatem415390001075091117158207225274347387414456529
preventivní469890001074976119159202249276294335383401
kardiologie.511690001073879105153171219238286335354397412
Kyselina3047104001074582117162181200248290
bempedoová3364104001075095170220265316365415455498
je3888104001072064
účinné3979104001074889108157205250
hypolipidemikum4256104001074887139189209227277297347391466485523572646
s49291040010734
nízkým4990104001074967105144187263
potenciálem527910400107511001281712203047118001074161103123169245
nežádoucích3320118001074995134178229279329372391433483
účinků,3831118001074991111160200250266
ověřené4125118001074991136163207258303
zejm.4456118001073882102178195
v46791180010742
klinické474911800107396180130150192231276
studii5053118001073465115166186205
CLEAR5286118001075394138194241
Outcomes.30471320010760107135173218291334367383
Ideální3446132001071967110150168215233
účinnost3694132001074887105152199246279307
vykazuje4017132001074083121162198246264307
v43401320010740
kombinační4396132001073784156205224270310350397415
léčbě4827132001071861102150194
a50371320010740
z50931320010735
prostředků5144132001074976122154183208250299336384
veřejného3047146001074184110153172220264312360
zdravotního3426146001073785111153193240268316334384433
pojištění3878146001074999118136169198240288307
je4204146001071963
hrazena4286146001074874116153196244285
v45901460010741
kombinaci4649146001073986160210229277317358376
s50441460010734
ezetimibem5097146001074481124152170244262312357430
u30471600010748
pacientů3114160001075091132151194243269317
s34511600010733
velmi3504160001074083103176195
vysokým3718160001074184118166205248322
a40601600010741
vysokým4120160001074184118166205248322
KV4462160001074494
rizikem457616000107264582101139182256
a48511600010741
hypercholesterolemií,49111600010749871381832092482963453644084424715135405873047174001071963137155174189
kteří3256174001073869111137157
netolerují3432174001074993121167187231257306325343
nebo3795174001074892142191
nemohou4006174001074892166214263311360
užívat4385174001074885104145187214
statin.4618174001073463104131150198214
PROHLÁŠENÍ48520400974286143197237289331372426447
AUTORŮ:948204009748100142197243296312
Prohlášení127520300984473118164185227260302348369
o1658203009845
původnosti:171620300984793134178225271317350379400419
Práce214920400954063100136173
je233720400951756
původní240720400954487123165209252269
a2690204009536
nebyla274020400954382126161179215
publikována296920400954487131148165198240276313355391
ani33752040095367895
není348420400954382125141
zaslána36402040095326999116152194230
k3885204009533
recenznímu39332040095236198136178211254271336378
řízení43252040095244173111154171
do451020400954386
jiného46102040095173476116158201
média.4826204009565104148165201215
Střet50562030098416997139168
zájmů:52382030098357799167212231
Žádný.48521600954380125168202213
Financování:71621500984161108149195232277318359406427446
Podpořeno117821600954082127171215239278321364
programem156021600954468110155179216282322387
Cooperatio.196521600954687131176217240278302319362376
Poděkování:235921500984590137180221266307348395416435
N/A.281121600955180122139
Registrace296821500984688135156190219248290326368
v3352215009841
databázích:341021500984687116158205247284306342389408
N/A.383521600955180122139
Projednání399121500984573119141183231278319365387
etickou43942150098417192128170214261
komisí:467121500984186155176210231250
N/A.493921600955180122139
LITERATURA426239001234978134189250318368438498567
1.42525600853648
Mach48925600835487119157
F,66125600833339
Baigent7152560083356884122157195217
C,94725600834053
Catapano10152560083407395128167200238276
AL,13062560083417387
et140825600833457
al.14802560083324760
[ESC15552560083195286127
Scientific16972560083336580115153174190207224256
Document196925600834584116154212247285307
Group].229125600834465102141180197209
2019251625600833468100130
ESC/EAS266125600833367107134168211245
Guidelines4252660083448297136171186201239274301
for7452660083185677
the8412660083226095
management95526600835790128160199234292327365387
of136026600833857
dyslipidaemias:14362660083387097112127166182221253288346361393419432
lipid1887266008315306984123
modification202926600835796135150168185217250272287325364
to241126600832259
reduce24892660083215594132164198
cardiovascular270526600833265861241391774252760083316490122159174206227
risk.664276008321366291105
Eur7822760083326889
Heart88427600834378109130154
J.105127600832436
2020;41(1):111-188.109927600833468100134147181211226257271282312339366385415446481494
Available160527600834171103118133165204219254
from18712760083184077134
DOI:201827600834593108120
<http://dx.doi.org/10.1093/21512760083417799123161174200220255286300338376391404441462500526558589602632663698730754
eurheartj/ehz455>.4252860083347293131166198219244259286317355385418451483522530
2.42529600853651
P488296008335
Roth5352960083357394132
GA,6792960083438498
Mensah78929600835489126152184222
GA,10232960083438498
Johnson113329600832462100137163200238
CO,13832960083408595
et149129600833355
al.15582960083324759
[GBD-NHLBI-JACC16302960083186095141164209253285320335357378417456493
Global21362960083435896135167182
Burden23302960083357393131165202
of254529600833755
Cardiovascular261329600833971921301441822132452714253060083316984117138
Diseases5763060083456187122154180215242
Writing8313060083587894116131169208
Group].105230600834466103141180198210
Global12753060083446098137170186
Burden14743060083357394132167205
of169330600833756
Cardiovascular17623060083407394132147185217250277309347362394416
Diseases21913060083456187122154180215242
and244630600833270109
Risk25683060083355177107
Factors,26883060083326294118155177204217
1990–2019:42531600833464100135173205239271301314
Update75831600834483122155176210
From9873160083335290148
the11543160083226095
GBD126831600834480126
2019141331600833468100130
Study.15623160083335492131163173
J1754316008324
Am179731600834199
Coll19153160083407793108
Cardiol.20423160083407394132147185201214
2020;76(25):2982-3021.227531600833468101135148181213232266301319331366400435469489522556589621630
Available42532600834171104120135167206222257
from6973260083194178136
DOI:84932600834593109122
<http://dx.doi.org/10.1016/j.jacc.2020.98632600834278100124164176203223259290304343381397410448469507533567598611641673705736761777790806838870901915951985101810521064
11.20663260083346171
010>.21523260083346697139147
3.42533600853651
Penson49033600833569107133171210
P,71433600833539
McGowan76733600835587132171222254292
M,107333600835568
Banach115533600833568106139171209
M.137833600835468
Evaluating14603360083336497113150182204219257296
bempedoic177033600833974132171207247285300332
acid21163360083326479118
for22483360083185677
the23393360083226095
treatment24483360083214377109131189224262283
of274533600833757
hyperlipidaemia.2816336008337684253460083387494110125163179217249283341356387400
Expert83834600833264104139160184
Opin103534600834686101138
Investig11863460083155283117143166181220
Drugs.141834600834567105143169182
2017;26(2):251-259.16133460083346799128137172205224257275287321356387405436470502513
Available213834600834171104118133165204220254
from24053460083184077134
DOI:255234600834593108121
<http://26853460083427899123162174201221
dx.doi.org/10.1080/13543784.2017.128045425356008338698312216017618922724828731334637739042145248852354758061064367971174377781382686289692795796399410241057109311291162
8>.16023560083347584
4.42536600853651
Pinkosky4893660083354987117154180210244
SL,7453660083336377
Newton83536600834479130154191229
RS,10763660083366982
Day117036600834577108
EA,12913660083327588
et139236600833456
al.14613660083314659
Liver-specific15333660083314679113134153180218254286301319335367
ATP-citrate191336600834169106127160175197218251273306
lyase22323660083154679105140
inhibition23853660083145289104143159181196234272
by266936600833970
bempedoic27513660083397413242537600833974114152167199
acid6393760083326479118
decreases77237600833873106127161193220255281
LDL-C106837600833278110125168
and125137600833270109
attenuates13753760083325378111149187219241275302
atherosclerosis.16923760083315391126148185212244259294315352379394420434
Nat21413760083447799
Commun.225537600833976135193230268281
2016;7:13457.255137600833569100132144177187217247282315348354
Available42538600834171104120135167206222257
from6973860083194178136
DOI:84938600834593109122
<http://dx.doi.98638600834278100124164176203223259290304343381397410
org/10.1038/ncomms13457>.14113860083375997123156188200231262295330355392424461519577603633663699731765805813
5.42539600853650
Ballantyne491396008335688499131169191224263298
CM,80539600834095108
Davidson92939600834678109125164190228267
MH,121239600835499112
Macdougall134039600835487119157195233272304320335
DE,16913960083457891
et179839600833457
al.18703960083324860
Efficacy1946396008333516886118151183217
and217939600833270109
safety23033960083276079113135169
of248839600833756
a2560396008332
novel260839600833776108142158
dual278139600833876108124
modulator42540600835796135173188220242279301
of74340600833757
adenosine81740600833271106144182209224262297
triphosphate-citrate1131406008322435998137175202240279311333367390424439461483516537571
lyase17204060083144679106141
and187840600833270109
adenosine200540600833170105143182208223261296
monophosphate-activated2319406008357951341722122502883153543934254474805045365684254160083223871104126161201
protein6474160083396198121155171209
kinase8774160083304785118145180
in107841600831554
patients11534160083397294110145184206234
with14084160083516790129
hypercholesterolemia:155741600833870110146168199238277293329356379414435473490525584599632644
results22224160083215683121136159187
of243041600833858
a2508416008333
multicenter,256141600835897112135151183217256278312334344
randomized,4254260083215493133171231246276310350363
double-blind,80942600833978116156172208231272288303342382395
placebo-controlled,12254260083395588120155194234258292329368390412450466482517557570
parallel-group18164260083397394128144159194210233274296334372412
trial.2249426008322446092108121
J2391426008324
Am2436426008342101
Coll25574260083417895110
Cardiol.26884260083407495134150188204218
2013;62(13):1154-1162.42543600833468100130141177210228259289306318348375405440463494522553586599
Available103743600834171104119134166206222256
from13064360083194178136
DOI:145543600834594110122
<http://dx.doi.org/10.1016/j.jacc.2013.159043600834278100124163176203223259290304343381396409447469507533566597610640672704735760776789805837869900913949983101510451057
05.26604360083346880
050>.275343600833569103144152
6.42544600853652
Cicero4944460083405587121142179
AFG,69044600834174118131
Fogacci83844600833370109142174205220
F,107544600833238
Hernandez113044600834479100139171209248283313
AV,14594460083417584
et155944600833457
al.16324460083324861
Lipid,17094460083324786102141153
Blood18794460083365189128168
Pressure20644460083355589116143180201235
Meta-231644600835590112145167
Analysis250044600834179111127159186200227
Collaboration274344600834077931081404254560083397799132154169207245
G,68445600834357
the7544560083215994
International8614560083155375108130168201222238276314346362
Lipid12364560083314786101140
Expert138945600833365105140161186
P.158845600833540
Efficacy1641456008333516986119151184217
and187145600833270109
safety19934560083265978113135169
of217545600833756
bempedoic224445600833974132171207246285300332
acid25894560083326479118
for27204560083185677
the28104560083226095
treatment4254660083224378110132190225264285
of73146600833857
hypercholesterolemia:80946600833768108144166197235274290325352375409431468484519577593625637
A1467466008341
systematic15294660083265986109143201234256271304
review18534660083215588104139190
and206446600833270109
meta-analysis.219446600835793115148171203242274290322349364390404
PLoS261846600833667105137
Med277546600835590130
2020;17(7):42547600833468101135148178208224259278290
e1003121.7294760083346495131164195225257266
Available100947600834172105120135167206222257
from12804760083184178136
DOI:143047600834594110122
http://dx.doi.org/10.1371/journal.pmed.10031211566476008338598312313516218221824926330234035636940742946749352655757060163166369571773377180983086990191793097010281063110211161146117812141247127813081339
7.304725600853645
Banach310925600833568106139171209
M,333425600835568
Duell341925600834584118134149
PB,35852560083357083
Gotto368425600834483105129166
AM386625600834197
Jr,39792560083254656
et405125600833457
al.41242560083324760
Association42012560083416995133166181213235250288327
of454425600833857
Bempedoic461725600833671129168204243281297329
Acid49622560083417388127
Administration510525600834180137152190205232255276309331346384423
With30472660083577496134
Atherogenic319726600834162101136157194234269307322354
Lipid35672660083314786101140
Levels37232660083316698132148174
in391326600831552
Phase398126600833673105132167
34164266008334
Randomized421426600833668106145184242257286320360
Clinical45902660083405570108123155188203
Trials4809266008333506597113139
of496426600833757
Patients50372660083356788104138176198226
With52792660083577396134
Hypercholesterolemia.54292660083447630472760083397495126164203219254280303337358396412446504519551565
JAMA363227600832464120162
Cardiol.38142760083407394132147185201214
2020;5(10):1124-1135.404927600833468101135148183200232263282294324351381413436467495524557569
Available463927600834171104119135167206222257
from49162760083184178136
DOI:507227600834694110122
<http://doi521527600834278100124163176203223259297312
10.1001/jamacardio.2020.2314>.30472860083346678109140177208230246278336369401434455493508546558594629661695708744779810841880888
8.304729600853651
Ridker31112960083355089118152173
PM,329729600833588101
Pradhan34112960083355587126164196233
A,365729600834054
MacFadyen372429600835486118150179218249283321
JG,40582960083246881
Libby41522960083314685124155
P,431929600833539
Glynn43712960083435990129166
RJ.45502960083356274
Cardiovascular46362960083407393131146183215248274306343358390411
benefits505929600833974111146163180202229
and530129600833269108
diabetes5422296008337528430473060083387394127153
risks3212306008321366190118
of334230600833755
statin34093060083264981102116153
therapy35743060083225993113146184214
in380030600831552
primary38643060083385974130161182215
prevention:40913060083385992124157194215230267304316
an441930600833168
analysis449930600833269100115146172186212
from47233060083183975132
the48673060083225993
JUPITER497230600832467102116149182217
trial.5201306008321425788103115
Lancet.532830600833164101132165186199
2012;11;380(9841):565-571.30473160083346798127139168195203237271305324356390426455469481515549582603636669701710
Available376931600834070102117131163201216250
from40323160083183976133
DOI:417731600834592107119
<http://doi43083160083427798122161172199218253291305
10.1016/S0140-6736(12)61190-8>.46263160083336476106137168198223255289320350385408445477510544562593622640674703730760795818853893901
9.304732600853649
Bays31173260083356899126
HE,32643260083447790
Banach337532600833568106138171209
M,360432600835568
Catapano36923260083407395128167200238277
AL,39893260083417387
et409632600833456
al.41733260083314760
Bempedoic425332600833671129168204243281297329
acid46023260083326479118
safety47413260083265978112135169
analysis:493032600833270102118149176191217230
Pooled518032600833672111127162201
data54023260083387092125
from30473360083184078136
four32003360083185694115
phase333233600833978110136171
33521336008334
clinical3572336008331466199114146179194
trials.3783336008322445991107133146
J3946336008324
Clin39873360083405670108
Lipidol.41123360083324786102141179195208
2020;14(5):649-659433733600833468101135148178209229262280292328364397421458492524
e6.48783360083347083
Available497833600834172105120135167207222257
from52523360083194178136
DOI:540533600834694110122
<http://dx.doi.org/10.1016/j.jacl.2020.304734600834278100124164176203223259290304343381397410448469507534567598611641673705736761777790806838870886899935969100210361048
08.41113460083346983
009>.420934600833470106147156
10.30473560085367085
Nicholls31523560083456092130168184199225
S,339735600833345
Lincoff34633560083314684116153173192
AM,367535600834197110
Bays38053560083356899126
HE,39513560083457891
et406235600833456
al.41383560083324760
Rationale42183560083366890106144182214230264
and450335600833169108
design46323560083387299114153191
of484335600833757
the49203560083216095
CLEAR-outcomes503535600834071104147183205244283305336373431466493
trial:3047366008322435991106118
Evaluating31843660083326497112150182204219257296
the34983660083226095
effect36123660083345372107139163
of379436600833756
bempedoic386936600833874132171207246284300332
acid42193660083326479118
on435536600833876
cardiovascular44503660083316485123138176208241267300337353385406
events487536600833466100138160187
in508136600831452
patients51523660083387193108143181203230
with54013660083506688127
statin30473760083265083105121159
intolerance.32273760083155375113129164186219258290324337
Am3585376008341100
Heart370637600834480112133158
J.388537600832537
2021;235:104-112.394337600833569103135143178214247258289320357381412440470483
Available444737600834172106121136169209225260
from47283760083194179138
DOI:488737600834695111123
<http://dx.doi.org/10.1016/j.ahj.2020.50313760083428010112616617920622726329530934838740341645447630473860083386497129141172204235267292308321355393408421457491524558571
10.36333860083346678
060>.372638600833570106147156
11.30473960085366678
Nissen31393960083456086113148186
SE,33383960083336578
Lincoff34303960083314785117154174193
AM,363639600834197110
Brennan37603960083355791129167199237
D,401139600834556
et408139600833456
al.41513960083324760
Bempedoic422539600833570128168203243281296328
acid45673960083326479118
and469939600833169109
cardiovascular48213960083326486124139177209242268301338354386407
outcomes52423960083377598128165224259285
in304740600831553
statin-intolerant31214060083264982104120158181197235257294310345367400438460
patients.36014060083397395110145183205233247
N3868406008345
Engl393440600833371110126
J4080406008325
Med.412540600835590130143
2023428940600833469102137
388(15):1353-1364.443540600833569105124156186205217247277310344366397427462499511
Available496740600834172105120136168208224259
from52474060083184078137
DOI:540440600834695111123
<http://dx.doi.org/10.1056/304741600834278100124164176203223259290304343381397410448469507534567598611641673707741766
NEJMoa2215024>.382941600834478104159197230265300331361395428460499507
12.30474260085366985
Tůmová315342600833369128167200234
E,340842600833346
Vrablík34754260083365791131147162195
M.369142600835569
Kyselina37814260083356593129145160199232
bempedoová403442600833975134174210250289329361395
v4450426008332
kontextu450342600833068108130164196221260
současných478442600832665104137170197236267299338
možností514342600835897126165204232255271
hypolipidemické54354260083386930474360083397793108147163202237295310342372406
léčby34684360083155083122153
a3636436008332
výsledků36834360083326693108143183213251
studie39494360083264987126142176
CLEAR414143600833971104147183
OUTCOMES.433943600834792126165210265299332346
AtheroRev.470043600834162100135157194230265297307
2023;8(2):85-94.502343600833468101136147182201235253265300334356391427439
13.30474460085366883
https://ec.europa.eu/health/documents/community-register/2020/20200612148391/31434460083375983122149161188208240272285320358379416455488501536573599638673705720742780806841879912950100710421080110111291155118312201278133613731411142614481482150315251559159916141640166316961717174017751809184218761900193519692001203520712107213721672198222922652298233123632385
anx_148391_cs.pdf304745600833270101139171202238272305337370403431445484524543
14.30474660085366984
https://ec.europa.eu/health/documents/community-register/2024/20240510162509/31444660083375983122149161188208239272285320357378415455487501535573599638672704719741779805841879911949100610411079110011281154118212191277133413721410142514471480150215241558159716121638166116951716173917731807184018721897193119651998202920652099213021612193222422572292232623612384
anx_162509_cs.pdf304747600833270101139171202235270304339374407435448488528547
Registrace:43877210020081153223257316364416484547622662
ole.fnol.cz50807210020780117192232275355435472511573633